CompletedPhase 2NCT00731016
Treatment of the Hutchinson-Gilford Progeria Syndrome With a Combination of Pravastatin and Zoledronic Acid
Studying Hutchinson-Gilford progeria syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Assistance Publique Hopitaux De Marseille
- Principal Investigator
- Nicolas LEVY, MDAssistance Publique des Hopitaux de Marseille
- Intervention
- Zoledronic acid, pravastatin(drug)
- Enrollment
- 15 target
- Eligibility
- 3 years · All sexes
- Timeline
- 2008 – 2013
Study locations (1)
- Laboratoire de Génétique Moléculaire - Hopital de la Timone, Marseille, France
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00731016 on ClinicalTrials.govOther trials for Hutchinson-Gilford progeria syndrome
Additional recruiting or active studies for the same condition.